Last reviewed · How we verify

StrataGraft

Stratatech, a Mallinckrodt Company · Phase 3 active Biologic

StrataGraft is a bioengineered human skin substitute used to treat severe burns.

StrataGraft is a bioengineered human skin substitute used to treat severe burns. Used for Treatment of severe burns.

At a glance

Generic nameStrataGraft
SponsorStratatech, a Mallinckrodt Company
Drug classSkin substitute
ModalityBiologic
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

StrataGraft is a bilayered, living skin substitute composed of a dermal layer and an epidermal layer. It is designed to promote wound healing and tissue regeneration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: